| 000 | 01517 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511141623.0 | ||
| 264 | 0 | _c19770622 | |
| 008 | 197706s 0 0 eng d | ||
| 022 | _a0028-1298 | ||
| 024 | 7 |
_a10.1007/BF00499921 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFarah, M B | |
| 245 | 0 | 0 |
_aPossible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat. _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cMar 1977 |
||
| 300 |
_a119-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCerebellar Cortex _xmetabolism |
| 650 | 0 | 4 |
_aCerebral Cortex _xmetabolism |
| 650 | 0 | 4 |
_aCocaine _xpharmacology |
| 650 | 0 | 4 |
_aHypothalamus _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethoxyhydroxyphenylglycol _xmetabolism |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aNormetanephrine _xmetabolism |
| 650 | 0 | 4 |
_aPargyline _xpharmacology |
| 650 | 0 | 4 |
_aPotassium _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aVanilmandelic Acid _xmetabolism |
| 700 | 1 | _aAdler-Graschinsky, E | |
| 700 | 1 | _aLanger, S Z | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 297 _gno. 2 _gp. 119-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00499921 _zAvailable from publisher's website |
| 999 |
_c605794 _d605794 |
||